Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Scientists create pigs resistant to PRRS
PRRS can lead to severe breathing problems in piglets and breeding failures in pregnant females.
Gene-editing technique could improve animal health

Scientists have used advanced gene editing techniques to create pigs that show signs of resistance to a major viral disease.

Writing in the journal Plos Pathogens, researchers describe how they produced pigs that are completely resistant to porcine reproductive and respiratory syndrome (PRRS).

The team claims the pigs are otherwise healthy and the change introduced using gene-editing technology should not affect their ability to stave off other infections.

“Genome-editing offers opportunities to boost food security be reducing waste and losses from infectious diseases, as well as improving animal welfare by reducing the burden of disease,” explained lead researcher Professor Alan Archibald of The Roslin Institute.

PRRS can lead to severe breathing problems in piglets and breeding failures in pregnant females. Endemic in most pig-producing companies, vaccines have, on the whole, failed to prevent the spread of the virus. In Europe alone, the disease is thought to cost the industry some €1.5billion every year.

Research conducted in the past shows that the PRRS virus targets immune cells called macrophages. A molecule on the surface of these cells called CD163 is essential in enabling the PRRS virus to establish an infection.

In the study, scientists used a gene editing tool called CRISPR/Cas9 to cut out a small section of the CD163 gene in the pigs’ DNA that interacts with the PRRS virus. Research shows that this change prevents the virus from causing infection.

Professor Bruce Whitelaw, interim director of the Roslin Institute described the project as an ‘elegant demonstration’ of how precise genome editing can be.

“We have deleted a single exon from the CD163 gene. The opportunity to use this technology to Improve animal health and productivity presents an exciting approach to address the food security and one health challenges,” he said.

The study was funded by the Biotechnology and Biological Sciences Research (BBSRC) Animal Research Club and Genus. 

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.